Holen Sie sich die Stockscreener-App
1.20
2.56%
0.03
Handel nachbörslich:
1.19
-0.01
-0.83%
Schlusskurs vom Vortag:
$1.17
Offen:
$1.18
24-Stunden-Volumen:
531.81K
Relative Volume:
0.14
Marktkapitalisierung:
$284.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.33M
KGV:
-1.8182
EPS:
-0.66
Netto-Cashflow:
$-13.21M
1W Leistung:
+22.45%
1M Leistung:
+60.49%
6M Leistung:
+6.95%
1J Leistung:
+4.35%
1-Tages-Spanne:
$1.17
$1.26
1-Wochen-Bereich:
$0.9201
$1.26
52-Wochen-Spanne:
$0.66
$2.10
Enlivex Therapeutics Ltd Stock (ENLV) Company Profile
Firmenname
Enlivex Therapeutics Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ENLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENLV
Enlivex Therapeutics Ltd
|
1.20 | 277.74M | 0 | -14.33M | -13.21M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Enlivex Therapeutics Ltd Stock (ENLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-02 | Bestätigt | H.C. Wainwright | Buy |
Enlivex Therapeutics Ltd Aktie (ENLV) Neueste Nachrichten
Enlivex Therapeutics (ENLV) Expands Reach with RAIN Token Listin - GuruFocus
Enlivex Lists RAIN Treasury Token on WhiteBIT to Boost Liquidity - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on WhiteBIT, a Leading Cryptocurrency Exchange - The Manila Times
Token powering real-world events markets lands on Europe’s top crypto exchange - Stock Titan
Analyst Upgrade: Is ProShares Trust ProShares Short Russell2000 forming bullish engulfing patternsWeekly Investment Recap & Community Driven Trade Alerts - baoquankhu1.vn
Can Enlivex Therapeutics Ltd sustain earnings growthMarket Movers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April By Investing.com - Investing.com India
Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq - MEXC
Enlivex Shares to Trade Exclusively on NASDAQ - Baystreet.ca
Enlivex Therapeutics to delist from Tel Aviv Stock Exchange in April - Investing.com Australia
Enlivex to Delist from Tel Aviv and Shift Trading Exclusively to Nasdaq - TipRanks
Biotech Enlivex shifts share trading to Nasdaq, leaves Tel Aviv in April - Stock Titan
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - norwichbulletin.com
Published on: 2026-01-22 15:37:58 - baoquankhu1.vn
Market Moves: What are Nukkleus Incs technical support levelsTrade Ideas & Short-Term High Return Strategies - baoquankhu1.vn
Guidance Update: Is Enlivex Therapeutics Ltd vulnerable to short sellers2025 Sector Review & Reliable Breakout Forecasts - baoquankhu1.vn
Risk Analysis: Can Enlivex Therapeutics Ltd reach all time highs this year2025 Trading Volume Trends & Weekly Stock Performance Updates - baoquankhu1.vn
Can Enlivex Therapeutics Ltd reach all time highs this yearQuarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Enlivex Therapeutics (NASDAQ:ENLV) Upgraded to Hold at Wall Street Zen - MarketBeat
Aug Spikes: Can Enlivex Therapeutics Ltd reach all time highs this yearAnalyst Upgrade & Safe Entry Trade Reports - baoquankhu1.vn
Breakouts Watch: Can Enlivex Therapeutics Ltd grow without external fundingJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
New Highs: Will Enlivex Therapeutics Ltd outperform its industry peers2025 Macro Impact & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Enlivex bets big on RAIN, crypto prediction markets - MEXC
Enlivex bets big on crypto prediction markets while advancing osteoarthritis therapy - Bitget
Analyst Sees Massive Upside For Penny Stock Enlivex After RAIN Token Gains Momentum - Benzinga
Enlivex Therapeutics (ENLV) Price Target Increased by 85.71% to 13.26 - Nasdaq
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update - MarketBeat
What is HC Wainwright's Estimate for ENLV FY2025 Earnings? - MarketBeat
Aug EndMonth: Is now the right time to enter Enlivex Therapeutics LtdMarket Volume Report & Technical Pattern Recognition Alerts - baoquankhu1.vn
Chart Watch: Is Enlivex Therapeutics Ltd stock affected by interest rate hikesStock Surge & AI Enhanced Execution Alerts - Bộ Nội Vụ
Enlivex Therapeutics Ltd. (ENLV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Enlivex Therapeutics stock price target raised to $13 by H.C. Wainwright - Investing.com South Africa
ENLV: Analyst Raises Price Target Significantly | ENLV Stock New - GuruFocus
Enlivex Completes Private Placement to Fund Digital Asset Strategy - MSN
VIX Spike: How Enlivex Therapeutics Ltd. stock reacts to bond yieldsQuarterly Market Summary & Breakout Confirmation Trade Signals - Улправда
Why Enlivex Therapeutics Ltd. stock could outperform in 2025Market Sentiment Review & Capital Efficient Trading Techniques - Улправда
Will Enlivex Therapeutics Ltd. stock rally after Fed decisionsEarnings Summary Report & Safe Entry Momentum Stock Tips - Улправда
Aug Wrap: How Enlivex Therapeutics Ltd. stock reacts to bond yieldsPortfolio Gains Report & Real-Time Market Trend Scan - Улправда
Tangible book value per share of Enlivex Therapeutics Ltd. – LSX:A119KH - TradingView — Track All Markets
Is Enlivex Therapeutics Ltd. stock oversold or undervaluedJuly 2025 Sentiment & Technical Buy Zone Confirmation - Улправда
Los Angeles Daily NewsEnlivex Therapeutics Ltd.Ordinary Shares (Nasdaq:ENLV) Stock Quote - FinancialContent
Enlivex Therapeutics (ENLV) Lists RAIN Token on KuCoin - GuruFocus
Enlivex Lists RAIN Treasury Token on KuCoin to Deepen Liquidity and Market Access - TipRanks
Enlivex Treasury Portfolio Update: Listing of the RAIN Token on KuCoin, a Leading Cryptocurrency Exchange - manilatimes.net
Finanzdaten der Enlivex Therapeutics Ltd-Aktie (ENLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):